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Abstract
Background: The accurate quantification of Plasmodium falciparum parasite numbers by PCR is an important tool
for monitoring growth kinetics in subjects infected and subsequently treated with anti-malarial agents.
Methods: A real-time quantitative PCR (rt-qPCR) method using primers and a hydrolysis probe that targets the 18S
rRNA gene was adapted and optimized to estimate parasite load in blood samples. Samples included laboratory
prepared blood samples of varying parasite concentrations (6.4 × 10
5 to 6.4 parasites per 500 μl of packed red
blood cells (500pRBC)) and blood samples collected from an experimentally infected human subject collected at 19
time points over 10 days. Sample preparation and extraction, detection chemistry, assay reproducibility, and limit of
detection were compared to a previously published SYBR Green rt-qPCR used in a malaria vaccine clinical trial.
Results: Both the rt-qPCR hydrolysis probe assay and SYBR Green rt-qPCR provided a limit of detection of 6.4 ×
10
1 parasites per 500pRBC. However non-specific amplification in the SYBR Green rt-qPCR assay led to either
inaccurate estimation of parasite load at levels below 6.4 × 10
2 parasites per 500pRBC and to false-positive
detection of parasites in negative samples. The rt-qPCR hydrolysis probe assay was specific and provided reliable
quantification of parasitaemia down to 6.4 × 10
1 parasites per 500pRBC. Notably, 12 of the 19 consecutive samples
collected from the experimentally infected subject were at or below 6.4 × 10
2 copies per 500pRBC.
Conclusions: These results show that the hydrolysis probe rt-qPCR assay is superior to the SYBR Green rt-qPCR for
the quantification of P. falciparum in human blood samples. The hydrolysis probe rt-qPCR is now in use in the
Queensland paediatric infectious diseases laboratory (QPID) to monitor parasitaemia in experimentally-infected
clinical trial subjects.
Background
Approximately one half of mankind is at risk of malaria
infection, with an estimated 243 million cases occurring
in 2008, resulting in an estimated 863,000 million deaths
[1]. The development of effective and affordable anti-
malarial drugs and vaccines is crucial in the fight against
malaria. To assess the efficacy of such anti-malarial
agents in clinical trials, sensitive and reliable laboratory
detection methods are required.
Until recently, the gold standard method for the diag-
nosis of malaria was examination of thin and thick
blood films, which has a predicted limit of detection of
5 to 20 parasites per microlitre of blood [2]. Subse-
quently, a range of diagnostic PCR assays have been
developed and these increase the sensitivity of detection
of blood-stage malarial parasites by at least a hundred-
fold compared with traditional microscopy [[3,4], and
[5]]. Recently real-time quantitative PCR (rt-qPCR)
assays have been specifically developed for use in
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any medium, provided the original work is properly cited.malaria vaccine clinical trials, successfully demonstrating
quantitative changes in parasitaemia [6]. These methods
included a filtration step to remove leukocytes, and
hence human DNA, from the blood during sample pre-
p a r a t i o n ,a n d ,h a v eu s e dt h ei n t e r c a l a t i n gd y eS Y B R
Green for the detection of amplification products.
Previously, the QPID laboratory described an rt-PCR
method for the sensitive detection and differentiation of
four Plasmodium species, including Plasmodium falci-
parum, using a common primer set and species-specific
hydrolysis probes targeting the 18S rRNA gene [7]. This
paper describes the adaptation of this method to allow
quantitative monitoring of changes in parasitaemia in
human subjects, and compared it to the SYBR Green
rt-qPCR method described by Andrews and colleagues [6].
The development of a hydrolysis probe rt-qPCR
method, sought to establish that the assay performed
with at least equal sensitivity and specificity to the SYBR
Green rt-qPCR method described previously by
Andrews et al [6]. This was achieved by determining the
experimental limit of detection of the two assays, and by
assessing their performance in the monitoring of parasi-
taemia in the blood of an experimentally infected sub-
j e c t .I na d d i t i o n ,w i t ht h eu s eo fas p e c i f i ch y d r o l y s i s
probe in the assay design it was determined if there is a
need to remove leukocytes from the patient’s blood.
Methods
Control specimens prepared for the evaluation of the
rt-PCR assays
Control standards were prepared for the comparative
evaluation of the SYBR Green rt-qPCR and hydrolysis
probe rt-qPCR methods. Specifically, malaria parasite
cultures of the P. falciparum 3D7 strain were main-
tained as described previously [8], and were grown to
between 3-7% parasitaemia. Two to four millilitres of
this culture were prepared for fluorescence-activated cell
sorting (FACS) as previously described [9]. Ethidium
bromide (EtBr) stained cultures were sorted by a FACS
Aria live cell sorter (Becton Dickson, San Jose, CA) into
96 well plates. A known number of parasites were
sorted into specific wells, ranging from 10 to 10
4 para-
sites. These parasites were able to be re-stained with
EtBr at a later time point and counted using a FACS
Canto II (Becton Dickson, San Jose, CA) with a high
throughput sampler option (HTS), to verify the number
of parasites present.
The control standards were prepared from the P. falci-
parum culture described above, as follows; laboratory-
infected blood samples were diluted in parasite-negative
whole blood or water to give final parasite concentra-
tions of 6.4 × 10
5,6 . 4×1 0
4,6 . 4×1 0
3,6 . 4×1 0
2,6 . 4×
10
1 parasites per 500pRBC. Standards of high parasite
load (6.4 × 10
5,6 . 4×1 0
4 and 6.4 × 10
3 parasites per
500pRBC) were tested in triplicate; lower standards (6.4
×1 0
2,6 . 4×1 0
1, and 6.4 parasites per 500pRBC) were
tested in replicates of ten.
Specimens from an experimentally infected volunteer
Nineteen sequentially collected blood samples from a
human volunteer who was experimentally infected with
P. falciparum 3D7 were used for the validation of the
quantitative PCR assays. Thisv o l u n t e e rw a sap a r t i c i -
pant in a larger study of the in vivo efficacy of anti-
malarial drug, to be described in more detail elsewhere
[McCarthy et al, manuscript in preparation]. Briefly, a
blood sample was taken pre-infection and then every
12 hours from Day 3 at 8 am, for 10 consecutive days.
Anti-malarial treatment was administered on Day 7 at
8 pm, and two extra blood samples were collected post
treatment at +6 and +18 hours). Following extraction of
the parasite DNA in these samples, extracts were tested
in triplicate to validate the rt-qPCR assays. Thick and
thin blood film preparations were also used to monitor
the volunteer’s parasitaemia at each time point.
Ethics approvals
The collection and analysis of samples described in this
study received the requisite approval from the Royal
Brisbane and Women’s Hospital Human Research Ethics
Committee (approval number 2008/003) and the
Queensland Institute for Medical Research Human
Ethics Committee (approval number p1286), respec-
tively. The clinical trial from which the patient samples
were collected was registered at ClinicalTrials.gov
(NCT01055002).
Sample preparation and nucleic acid extraction
FACs counted P. falciparum control standards
(described above) were used to determine the need for
leukocyte removal by filtration as described by Andrews
et al [6]. It was assumed that the removal of unrelated
(human) DNA would improve the specificity of a SYBR
Green rt-qPCR assay, but is not necessary for the more
specific hydrolysis probe rt-qPCR. Fresh control stan-
dards were diluted with parasite free whole blood to
final parasite concentrations of 5.0 × 10
5,1 . 0×1 0
5,
2.0 × 10
3, 1.0 × 10
3, 5.0 × 10
2, 2.5 × 10
2, 1.0 × 10
2 para-
sites per 500pRBC. These sample dilutions were then
processed with and without Plasmodir filtration. Briefly,
samples for filtration were centrifuged and plasma was
removed. To each sample 2.5 ml of sterile PBS was
added, the suspension was mixed by inversion, and
passed through a Plasmodipur filter (Euro Diagnostica
BV, Arnhem, The Netherlands). An additional 3.5 ml of
sterile PBS was used to flush the filter and wash out
remaining red blood cells (RBC). Samples were then
centrifuged and supernatant was removed. 500 μlo ft h e
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and the remainder stored at -80°C.
For unfiltered samples, 2 ml of whole blood was cen-
trifuged for 5 minutes at 2500 rpm. 500 μlo fp a c k e d
red cells was removed and added to 500 μlo fP B Sa n d
mixed thoroughly. The packed red blood samples were
split into two 1.5 ml tubes containing 500 μl in each ali-
quot. The DNA from one of these was extracted imme-
diately, and the second aliquot was stored at -80°C.
Before DNA extraction, 10
4 copies of equine herpes
virus (EHV) DNA (Cp = 30) were added to each of the
filtered and unfiltered sample dilutions to monitor the
efficiency and reproducibility of the extraction process
[10]. Nucleic acid was then extracted using the QIAamp
DNA Mini kit (QIAGEN, Australia) following the manu-
facturer’s instructions. Extraction of nucleic acid was
achieved by adding 40 μlo fQ i a g e nP r o t e a s eKa n d
incubating each sample at 56°C for 10 minutes. 400 μl
of 100% ethanol was added and mixed thoroughly.
Nucleic acid extracts were eluted in 100 μlo fe l u t i o n
buffer and stored at -80°C until PCR reactions were per-
formed. After extraction each standard was tested by
PCR in triplicate, and quantified using a standard curve
of predetermined parasitaemia.
Real-time quantitative PCR methods
SYBR green rt-qPCR assay
This method was adapted from the assay previously
described by Andrews et al [6] Briefly, the PCR mix
consisted of 12.5 μl Quantitect SYBR Green PCR Mix
(Qiagen, Australia), 0.3 μM of each primer (18SRank1F:
GTT CTG GGG CGA CTA T and 18SRank1R: TGC
A T CA C CA T CC A AG ) ,4m Mo fM g C l 2 and 5 μlo f
template DNA in a 25 μl final reaction mix. PCR was
performed in a Rotorgene 3000 or 6000 (Qiagen, Aus-
tralia) under the following conditions: 15 minutes incu-
bation at 95°C, followed by 45 cycles of 94°C for
5 seconds, 50°C for 15 seconds and 72°C for 10 seconds.
A melt curve analysis step was added with a melting
profile of 50 - 94°C at 1°C per second.
Hydrolysis probe rt-qPCR assay
The oligonucleotides and cycling conditions used were
those previously developed in the QPID laboratory [7].
Briefly, the reaction mix consisted of 12.5 μlQ u a n t i t e c t
Probe PCR Mix (Qiagen, Australia), 10 pmol of each
primer (PerFAL-Forward: CTT TTG AGA GGT TTT
GTT ACT TTG AGT AA and PerFAL-Reverse: TAT
TCC ATG CTG TAG TAT TCA AAC ACA), 4 pmol of
probe (PerFAL-probe: Fam-TGT TCA TAA CAG ACG
GGT AGT CAT GAT TGA GTT CA-BHQ1) and 5 μl
of template DNA in a 25 μl final reaction volume.
Amplification was performed in a Rotorgene 3000 or
6000 (Qiagen, Australia) under the following conditions:
15 minutes incubation at 95°C, followed by 45 cycles of
95°C for 15 seconds and 60°C for 1 minute.
Standard curve
Serial dilutions were prepared from laboratory cultures
of P. falciparum. Six standards were used on each run
ranging from 6.4 × 10
5 to 6.4 parasites per 500pRBC
and two negative controls consisting of sterile water.
Parasite concentration was extrapolated from crossing
point (Cp) values by a simple linear regression model in
the form y = mx+b using Qiagen, Rotorgene software
(Qiagen, Australia).
Results
Sensitivity and specificity of rt-qPCR assays
Serial dilutions of FACs counted P. falciparum 3D7
infected RBC were used to evaluate the sensitivity and
specificity of each assay. The limit of detection for both
the rt-qPCR hydrolysis probe assay and SYBR Green rt-
qPCR is, 6.4 × 10
1 parasites per 500pRBC (Table 1).
Interestingly, amplification of parasite DNA was affected
by the medium used to dilute the infected RBC. Cp
values were reduced by approximately two cycles with
the addition of parasite-negative blood nucleic acid
extract using the rt-qPCR SYBR Green assay but not in
the hydrolysis probe rt-qPCR. This suggests that the
SYBR Green assay may non-specifically amplify human
DNA and thereby affects the accuracy of parasite quan-
tification. The reliable detection of 6.4 parasites per
500pRBC was limited in both assays with only one repli-
cate being amplified in both water and parasite-negative
blood extract dilutions using the hydrolysis probe assay.
However, the SYBR Green rt-qPCR assay showed ampli-
fication in all 10 replicates at the 6.4 parasites per
p500pRBC dilution in parasite-negative whole blood
extract, and only one positive replicate in extracts
d i l u t e di nw a t e r .M e l ta n a l y s i sr e v e a l e dt h a t7o f1 0
amplification products showed a shift in melt peak from
82°C a temperature which is characteristic of a specific
amplification product to 79°C, which is indicative of
unrelated amplicons. Non-specific melt peaks were also
noted in seven out of 10 amplification reactions at 64
parasites per 500pRBC diluted in parasite-negative blood
extract.
Removal of leukocytes from blood samples
Pre-treatment of the P. falciparum control standards by
Plasmodir filtration showed that there was no significant
difference in both the Cp values and the estimated num-
ber of parasites for each dilution tested. These results
were consistent when tested by either the SYBR Green
rt-qPCR assay or the hydrolysis probe rt-qPCR assay
(Table 2). Interestingly, filtration did not remove non
specific amplification using the SYBR Green assay, with
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2 in both fil-
tered and unfiltered standards.
Validation of the rt-qPCR methods
Both the SYBR Green and hydrolysis probe rt-qPCR
were evaluated for their ability to accurately monitor
parasitaemia in an experimentally infected subject
(Table 3). The hydrolysis probe rt-qPCR did not detect
parasite DNA in any of the triplicate extracts from the
pre-infection control, whereas the SYBR Green rt-qPCR
recorded a positive result for each of the three replicates
(Table 3). Similarly, no parasites were detected in the
samples collected at Day 4 pm and Day 10 pm by the
hydrolysis probe rt-qPCR, yet showed two of three posi-
tive results and one of three positive results with the
SYBR Green assay respectively. Further characterization
of these amplification products by melting peak analysis
showed that the product amplified with the SYBR Green
assay gave a melting temperature of 79°C which was
characteristic of non-specific amplification, compared to
the expected melting temperature of 82°C for the speci-
fic amplicon. Apart from the above, both assays showed
Table 1 Sensitivity and specificity of rt-qPCR Assays using hydrolysis probes and SYBR Green to quantify laboratory
prepared dilutions of Plasmodium falciparum
Dilutions (replicates) Hydrolysis probe SYBR Green
Crossing point (SD), Quant value (SD)
In Water 6.4 × 10
5 (×3) 24.6 (0.06), 670 000 (28 000) 20.5 (0.10), 740 000 (48 000)
6.4 × 10
4 (×3) 28.2 (0.09), 60 000 (3 700) 24.6 (0.68), 57 000 (27 000)
6.4 × 10
3 (×3) 30.8 (0.50), 9 200 (1 600) 27.6 (0.38), 8 100 (1 600)
6.4 × 10
2 (×10) 34.6 (0.40), 550 (140) 32.9 (0.57), 550 (200)
6.4 × 10
1 (×10) 37.9 (0.55), 56 (20) 36.1 (1.46), 90 (70)
6.4 (×10) 37.9 (n/a), 52 (n/a) 40.39 (n/a), 4 (n/a)
In Negative Extract 6.4 × 10
5 (×3) 24.7 (0.02), 650 000 (8 600) 23.0 (0.22), 710000 (100 000)
6.4 × 10
4 (×3) 28.1(0.20), 62 000 (8 400) 26.6 (0.21), 61 000 (8 200)
6.4 × 10
3 (×3) 30.7 (0.41), 6 800 (1 200) 30.1 (0.44), 7,600 (2 600)
6.4 × 10
2 (×10) 33.5 (0.24), 660 (120) 34.7 (0.37), 410 (120)
6.4 × 10
1 (×10) 37.2 (1.09), 60 (50) 37.2
a (1.22), 90 (90)
6.4 (×10) 37.6 (n/a), 40 (n/a) 39.7
a (1.75), 25 (45)
a Indicates nonspecific melting peaks of 79°C obtained by melting curve analysis of replicates tested.
n/a = Not Applicable.
SD = Standard Deviation.
Table 2 Evaluation of Filtration methods to improve sensitivity and specificity of rt-qPCR assays
Dilutions (3 × replicates) Hydrolysis probe assay SYBR Green assay
Crossing point (SD), Quant value (SD)
Filtered 5.0 × 10
5 23.38 (0.03), 540 000 (9 000) 20.95 (0.68) 850 000 (400 000)
1.0 × 10
5 25.36 (0.16) 160 000 (16 000) 24.20 (0.44) 81 000 (26 000)
2.0 × 10
4 28.33 (0.17) 27 000 (3000) 26.14 (0.31) 20 000 (4000)
1.0 × 10
3 33.74 (0.44) 1000 (300) 32.65 (0.49) 200 (70)
5.0 × 10
2 34.64 (0.45) 600 (160) 33.29 (1.24) 160 (130)
2.5 × 10
2 37.40 (n/a) 110 (n/a) 37.02 (1.05)
a 10 (10)
1.0 ×02 Not detected False Positive 20 (10)
Unfiltered 5.0 × 10
5 24.53 (0.62) 300 000 (94 000) 22.83 (0.46) 200 000 (70 000)
1.0 × 10
5 25.46 (0.35) 156 000 (33 000) 24.50 (0.11) 64 000 (4800)
2.0 × 10
4 29.15 (0.05) 17 000 (500) 29.85 (0.44) 1500 (500)
1.0 × 10
3 33.81 (0.38) 1000 (220) 32.98 (0.16) 160 (20)
5.0 × 10
2 35.27 (1.63) 550 (450) 36.38 (0.23)
a 15 (3)
2.5 × 10
2 38.35 (1.06) 75 (50) 35.63 (0.73)
a 30 (10)
1.0 ×02 Not detected False Positive 10 (2)
a Indicates nonspecific melting peaks of 79°C obtained by melting curve analysis of replicates tested.
n/a = Not Applicable.
SD = Standard Deviation.
ND = Not Detected.
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lected after three days following inoculation. The SYBR
Green rt-qPCR showed non-specific amplification in all
replicates at 3, 4, 6, 9 and 10 days post infection (melt-
ing temperature of 79°). No parasites were detected in
any of the blood films (thin and thick) collected from
this subject during the course of the trial.
Discussion
Sensitive and reliable malaria rt-qPCR assays are becom-
ing increasingly important for a range of purposes in
clinical studies of human malaria. To date SYBR Green
rt-qPCR assays have been the most widely used methods
for the quantification of parasite load. However, from a
technical point of view, the SYBR Green detection
method has some limitations. It is an intercalating dye
that binds to all double-stranded DNA produced during
a PCR reaction, including non-specific amplification
products from unrelated nucleic acids present in the
sample, such as human DNA extracted from leukocytes.
This limitation does not apply for rt-qPCR using hydro-
lysis probes, as the detection signal is only produced
from complementary DNA sequence. Therefore, the use
of a hydrolysis probe rt-qPCR results in specific amplifi-
cation, increasing the accuracy of the estimated parasi-
taemia in the blood sample. In previous studies,
researchers have included a filtration step in the sample
preparation procedure, to deplete excess human geno-
mic DNA by removing leukocytes. However, this proce-
dure is cumbersome, time consuming and expensive.
The rt-qPCR method described here does not require
the additional filtration step as the more specific hydro-
lysis probe detection method removes the problem of
non-specific amplification. The results obtained in this
study showed that the limit of detection of the two
assays was similar at 64 parasites per 500pRBC. How-
ever, it was demonstrated by melting curve analysis that
some of the SYBR Green assay results may be affected
by non-specific binding of the intercalating dye, leading
to inaccurate estimation of parasitaemia.
This phenomenon was also evident in the validation of
the assay using samples collected from an experimen-
tally infected subject, further suggesting that the hydro-
lysis probe rt-qPCR assay is superior when used for the
estimation of parasitaemia in human clinical studies.
This was supported by the results which show that the
Table 3 Quantification of parasitaemia in a experimental infected subject, over 10 days and 19 time points with two
rt-qPCR assays
Hydrolysis probe assay SYBR Green assay
Dilutions (3×
replicates)
Replicates
positive
Cp,(SD) Quant value
(SD)
Replicates
positive
Cp,(SD) Quant value
(SD)
Specific melt 82°C
Pre-infection 0/3 ND 3/3 36.8 (0.13)
a False Positive 0/3
Day 3 AM 1/3 39.6 (n/a) 18 (n/a) 3/3 37.4 (0.29)
a 10 (3) 2/3
Day 3 PM 2/3 38.1 (1.2) 60 (40) 3/3 36.8 (0.44)
a 20 (7) 0/3
Day 4 AM 3/3 38.4 (0.59) 40 (20) 3/3 36.8 (0.83)
a 20 (15) 1/3
Day 4 PM 0/3 ND 3/3 36.3 (0.23)
a False Positive 2/3
Day 5 AM 3/3 33.9 (0.27) 900 (180) 3/3 33.2 (0.45) 320 (100) 3/3
Day 5 PM 3/3 33.2 (0.04) 1400 (40) 3/3 32.3 (0.64) 700 (300) 3/3
Day 6 AM 3/3 37.7 (0.85) 70 (40) 3/3 36.9 (0.80)
a 20 (13) 2/3
Day 6 PM 3/3 30.3 (0.14) 10100 (1000) 3/3 29.6 (0.68) 5900 (3000) 3/3
Day 7 AM 3/3 29.2 (0.23) 22000 (3300) 3/3 27.3 (0.30) 32000 (7600) 3/3
Day 7 PM * 3/3 31.2 (0.07) 5600 (270) 3/3 29.8 (0.62) 4900 (2100) 3/3
Day 7 PM+6 hrs 3/3 33.5 (0.55) 1200 (400) 3/3 31.7 (0.19) 1100 (160) 3/3
Day 8 AM 3/3 34.8 (0.13) 460 (40) 3/3 33.0 (0.39) 400 (130) 3/3
Day 8 AM+6 hrs 3/3 35.7 (0.91) 300 (140) 3/3 34.4 (0.30) 130 (30) 3/3
Day 8 PM 3/3 37.1 (1.42) 130 (100) 3/3 34.4 (0.45) 140 (40) 3/3
Day 9 AM 2/3 38.9 (0.38) 30 (20) 3/3 35.0 (0.10)
a 80 (6) 2/3
Day 9 PM 1/3 39.35 (n/a) 20 (n/a) 3/3 36.1 (0.44)
a 40 (10) 1/3
Day 10 AM 1/3 39.05 (n/a) 30 (n/a) 3/3 37.0 (1.08)
a 20 (18) 1/3
Day 10 PM 0/3 ND 3/3 36.8 (0.09)
a False Positive 1/3
*Administration of anti-malarial treatment at this time point.
a Indicates nonspecific melting peaks of 79°C obtained by melting curve analysis of replicates tested.
Cp = Crossing point.
n/a = not applicable.
SD = Standard Deviation.
ND = Not Detected.
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tion was not necessary, when the hydrolysis probe
rt-qPCR assay was used.
In the clinical trial samples, both rt-qPCR assays
detected parasites in the majority of blood samples col-
lected during the course of the trial. However, no para-
sites were detected in any samples by traditional blood
film microscopy, reflecting the superior sensitivity of the
molecular methods.
It should be noted however, that the rt-qPCR method
described can only be applied accurately in the relative
quantification of parasitaemia in sequentially collected
samples. If this method were to be used for quantifica-
tion of parasites in individual samples, then minor varia-
tion in any of several assay parameters (including
extraction efficiency and PCR reproducibility) may lead
to significant variation in results and therefore further
assay quality assurance should be utilized. This was not
necessary for the monitoring of parasitaemia in experi-
mentally infected subjects, because sequentially collected
blood samples were tested in a single assay.
Conclusions
This paper describes a sensitive and specific rt-qPCR
protocol using a TaqMan hydrolysis probe to monitor
the presence and replication kinetics of P. falciparum in
experimentally infected human subjects. This method is
now in use in the QPID laboratory to monitor parasitae-
mia before and, after treatment with an anti-malarial
agent. Clear improvements were recorded in processing
times and specificity when compared to previously pub-
lished SYBR Green rt-qPCR assay [6]. The hydrolysis
probe rt-qPCR assay has subsequently become our
method of choice for monitoring anti-malarial drug effi-
cacy in clinical trial subjects.
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